Opaleye Management Inc.'s Form 4 filing
Tracon Pharmaceuticals, Inc. (TCON) · filed Dec 15, 2021
- Accession no.
- 0001493152-21-031568
- Filed
- Dec 15, 2021
- Trade date
- Dec 13-14, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market purchases total $146.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Opaleye Management Inc.CIK 0001595855 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2021 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +14,000 | $2.64 | +$36,960 | 2,462,371 | Indirect | |
| Dec 13, 2021 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +1,204 | $2.64 | +$3,178.56 | 243,711 | Indirect | |
| Dec 14, 2021 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +35,000 | $2.53 | +$88,550 | 2,497,371 | Indirect | |
| Dec 14, 2021 | Common Stock, par value $0.001 per share | PPurchaseAcquired | +7,000 | $2.53 | +$17,710 | 250,711 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.